HC Wainwright Issues Negative Estimate for DRUG Earnings
Research analysts at HC Wainwright decreased their Q3 2025 earnings estimates for shares of Bright Minds Biosciences in a ...
Equities Analysts Issue Forecasts for AVXL Q2 Earnings
Stock analysts at HC Wainwright lifted their Q2 2025 earnings per share (EPS) estimates for shares of Anavex Life Sciences in ...
Balchem projects strong 2025 growth amid new product launches and robust segment performance
Q4 2024 Management View According to Ted Harris, Chairman, President, and CEO, Balchem achieved record consolidated sales of $240 million in Q4 2024, representing 4.9% growth year-over-year. Adjusted ...
Q4 2024 Balchem Corp Earnings Call
Martin Bengtsson; Chief Financial Officer, Executive Vice President; Balchem Corp Theodore Harris; Chairman of the Board, President, Chief Executive Officer; Balchem Corp Please note that this ...